New hope for kidney transplant patients: safer Anti-Rejection drug tested
Disease control
ENROLLING_BY_INVITATION
This study tests a new drug called tegoprubart in people who have received a kidney transplant. The goal is to see if it is safe and works well over the long term compared to the standard drug tacrolimus. About 132 adults who completed a prior related study will take part. The ap…
Phase: PHASE2 • Sponsor: Eledon Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:52 UTC